Skip to main content
TipRanks
Go Ultimate75% OFF

Bruce Lewis Insider Profile

4 Followers

Bruce Lewis, Director at Biosenta Inc, holds 6.10M shares in Biosenta Inc (Ticker: TSE:ZRO). Most recently, Bruce Lewis Bought 1,368,000 shares of Biosenta Inc on Feb 09, 2015 for an estimated value of C$169.63K.

Bruce Lewis's Trading History

ZRO
Biosenta Inc
Feb 09, 2015DirectorInformative Buy169.63KC$274.41K
TSE:ZRO
Insider Shares: 6.10M (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 09, 2015Informative BuyC$169.63K1,368,000C$0.12-50.10%―
Dec 24, 2014Informative SellC$120.00K3,000,000C$0.04+50.00%―
Oct 09, 2014Informative SellC$13.85K115,385C$0.12+81.80%―
Jul 31, 2014Informative SellC$48.00K400,000C$0.12+80.00%―
Jun 30, 2014Uninformative BuyC$0.001,000,000C$0.00――

You May Also Like

Bruce Lewis insider profile FAQ

What is the percentage of profitable transactions made by Bruce Lewis?
The percentage of profitable transactions made by Bruce Lewis is 68%.
What is the average return per transaction made by Bruce Lewis?
The average return per transaction made by Bruce Lewis is 22.50%.
What stocks does Bruce Lewis hold?
Bruce Lewis holds: TSE:ZRO stocks.
What was Bruce Lewis’s latest transaction?
Bruce Lewis’s latest transaction was an Informative Buy of C$169.63K.
What was Bruce Lewis's most profitable transaction?
Bruce Lewis’s most profitable transaction was an Informative Buy of TSE:ZRO stock on March 27, 2014. The return on the trade was 159.80%.
What is Bruce Lewis's role in Biosenta Inc?
Bruce Lewis's role in Biosenta Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.